# Eli Lilly and Company – FDA Inspection, Sep 11, 2025

Source: https://www.keypedia.com/records/fda_inspections/eli-lilly-and-company/d715afa3-358a-4c9f-b4e4-13b0afa04843
Source feed: FDA_Inspections

> FDA inspection 1282100 of Eli Lilly and Company, September 11, 2025. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1282100
- Company Name: Eli Lilly and Company
- Inspection Date: 2025-09-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Minneapolis District Office
- Citation Count: 2

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jacob-g-lutz/ca2710c6-064f-4728-9129-aad73e74f12d)
- [Melissa M. Steiger](https://www.keypedia.com/people/melissa-m-steiger/513a7364-15df-474f-8a8a-b5c4ff1cf59f)
- [Issuing Officer](https://www.keypedia.com/people/tianhong-zhou/469d9b6b-026a-4c00-b8b9-07e67e96bc22)

Company: https://www.keypedia.com/companies/eli-lilly-and-company/8a6d3dc2-168f-4196-8a63-12b1f113e12a

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d
